These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15637639

  • 1. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
    Panayi F, Colussi-Mas J, Lambás-Señas L, Renaud B, Scarna H, Bérod A.
    Neuropsychopharmacology; 2005 May; 30(5):871-9. PubMed ID: 15637639
    [Abstract] [Full Text] [Related]

  • 2. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
    Leonetti M, Brun P, Sotty F, Steinberg R, Soubrié P, Bert L, Renaud B, Suaud-Chagny MF.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
    [Abstract] [Full Text] [Related]

  • 3. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F, Dorso E, Lambás-Señas L, Renaud B, Scarna H, Bérod A.
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [Abstract] [Full Text] [Related]

  • 4. Sensitization to amphetamine psychostimulant effect: A key role for ventral tegmental area neurotensin type 2 receptors and MAP kinase pathway.
    Voyer D, Einsiedel J, Gmeiner P, Lévesque D, Rompré PP.
    Addict Biol; 2021 Sep; 26(5):e13008. PubMed ID: 33491227
    [Abstract] [Full Text] [Related]

  • 5. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
    Tolliver BK, Ho LB, Fox LM, Berger SP.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):38-47. PubMed ID: 10086985
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
    Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N, Pecceu F, Labbé-Jullié C, Kitabgi P, Soubrié P, Le Fur G, Maffrand JP.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
    [Abstract] [Full Text] [Related]

  • 7. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P, Rompré PP.
    Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
    [Abstract] [Full Text] [Related]

  • 8. Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice.
    Casti P, Marchese G, Casu G, Ruiu S, Pani L.
    Neuropharmacology; 2004 Jul; 47(1):128-35. PubMed ID: 15165840
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization.
    Rompré P, Perron S.
    Neuropharmacology; 2000 Jul 24; 39(10):1880-92. PubMed ID: 10884569
    [Abstract] [Full Text] [Related]

  • 10. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area.
    Vezina P, Queen AL.
    Psychopharmacology (Berl); 2000 Aug 24; 151(2-3):184-91. PubMed ID: 10972464
    [Abstract] [Full Text] [Related]

  • 11. The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
    Cáceda R, Binder EB, Kinkead B, Nemeroff CB.
    Schizophr Res; 2012 Apr 24; 136(1-3):88-95. PubMed ID: 22104138
    [Abstract] [Full Text] [Related]

  • 12. Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostrobasal forebrain to the ventral tegmental area.
    Reynolds SM, Geisler S, Bérod A, Zahm DS.
    Eur J Neurosci; 2006 Jul 24; 24(1):188-96. PubMed ID: 16882016
    [Abstract] [Full Text] [Related]

  • 13. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
    Brun P, Leonetti M, Sotty F, Steinberg R, Soubrié P, Renaud B, Suaud-Chagny MF.
    J Neurochem; 2001 Jun 24; 77(6):1542-52. PubMed ID: 11413237
    [Abstract] [Full Text] [Related]

  • 14. Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats.
    Champtiaux N, Kalivas PW, Bardo MT.
    Behav Brain Res; 2006 Mar 15; 168(1):120-6. PubMed ID: 16313978
    [Abstract] [Full Text] [Related]

  • 15. Neurotensin afferents of the ventral tegmental area in the rat: [1] re-examination of their origins and [2] responses to acute psychostimulant and antipsychotic drug administration.
    Geisler S, Zahm DS.
    Eur J Neurosci; 2006 Jul 15; 24(1):116-34. PubMed ID: 16882012
    [Abstract] [Full Text] [Related]

  • 16. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
    Kalivas PW, Alesdatter JE.
    J Pharmacol Exp Ther; 1993 Oct 15; 267(1):486-95. PubMed ID: 8229779
    [Abstract] [Full Text] [Related]

  • 17. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
    Bjijou Y, Stinus L, Le Moal M, Cador M.
    J Pharmacol Exp Ther; 1996 May 15; 277(2):1177-87. PubMed ID: 8627530
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects.
    Chen JC, Liang KW, Huang EY.
    Synapse; 2001 Mar 01; 39(3):239-48. PubMed ID: 11169772
    [Abstract] [Full Text] [Related]

  • 19. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM, Tapocik J, Gaval-Cruz M, Kabbaj M.
    Physiol Behav; 2005 Oct 15; 86(3):347-55. PubMed ID: 16126238
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor.
    Johnston CE, Herschel DJ, Lasek AW, Hammer RP, Nikulina EM.
    Neuropharmacology; 2015 Feb 15; 89():325-34. PubMed ID: 25446676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.